News & Events

• April 15, 2019
  

  Muscular Dystrophy Association 2019 Clinical and Scientific Conference

  Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Orlando, FL on April 14- April 16. She presented two posters: Development of a Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Consortium Value of Skeletal Muscle Damage Biomarkers as Pharmacodynamic Biomarkers for Neuromuscular......
• March 17, 2019
  

  Increasing Efficiency, Safety, and Speed in Clinical Trials for Neurodegenerative Diseases | Alzheimer’s Drug Discovery Foundation Conference, Long Beach, CA

• March 13, 2019 - March 16, 2019
  

  Poster presentation at the American Society for Clinical Pharmacology & Therapeutics Meeting, March 13-16, 2019, Washington, DC

• February 19, 2019
  

  Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration | 7th World CNS Summit, Boston, MA

• November 10, 2018
  

  Comparability of a Provisioned Device Versus Bring Your Own Device for Completion of Patient-Reported Outcome (PRO) Measures by Participants with Chronic Obstructive Pulmonary Disease (COPD): Qualitative Interview Findings